Half of patients in Cedars-Sinai glioblastoma study still alive after 5 years

Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors - glioblastoma multiforme - survived longer than five years after diagnosis, according to Cedars-Sinai researchers, who presented findings at the Fourth Quadrennial Meeting of the World Federation of ... (more)

http://www.medicalnewstoday.com/releases/269276.php